IPC appoints 5 new councilors

They join an esteemed group of IPC psoriasis experts working to better patient care

We are pleased to introduce our newest IPC Councilors, including, for the first time, dermatologists from Bangladesh and Guatemala. Councilors are selected based on overall reputation in the dermatology community, involvement in psoriasis research, and demonstrated interest in psoriasis care and treatment.

Meet our councilors

Charlotte Enerbäck, MD, PhD
Linköping University
Linköping, Sweden

Joseph Merola, MD, MMSc
Harvard Medical School
Boston, Massachusetts, United States

Mohammad Rafiqul Mowla, MBBS, MD
Chittagong Medical College
Chittagong, Bangladesh

Stefano Piaserico, MD, PhD
University of Padua, Italy
Padua, Italy

Enrique Rivas, MD
DERMOS Research Center
Guatemala City, Guatemala

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Mona El-Kalioby, MBBCh, MSc, MD

Psoriasis and the Pandemic: Lessons Learned from PsoProtect

Boehringer Ingelheim’s SPEVIGO® Receives Breakthrough Therapy Designation (BTD) from the United States Food and Drug Administration (FDA)

Also Read

Fellowship Program

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Mona El-Kalioby, MBBCh, MSc, MD

Learn about Mona El-Kalioby’s experience as a 2022 participant in IPC’s International Fellowship Program. In this exclusive interview, she shares how the program helped her personally and professionally.

Tuesday, May 30, 2023

Fellows

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Juul van den Reek, MD, PhD

Learn about Juul van den Reek’s experience as a 2022 participant in IPC’s International Fellowship Program. In this exclusive interview, she shares how the program helped her expand her psoriasis research internationally and build valuable connections with experts in the field.

Wednesday, April 26, 2023

IPC News

Meet our Newest Councilors

Introducing IPC’s newest Councilors for 2023: A cohort of global experts dedicated to improving patient care for psoriasis.

Monday, April 24, 2023

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

IPC appoints 5 new councilors

They join an esteemed group of IPC psoriasis experts working to better patient care

Meet our councilors

Categories

Recent Posts

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Mona El-Kalioby, MBBCh, MSc, MD

Psoriasis and the Pandemic: Lessons Learned from PsoProtect

Boehringer Ingelheim’s SPEVIGO® Receives Breakthrough Therapy Designation (BTD) from the United States Food and Drug Administration (FDA)

Also Read

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Mona El-Kalioby, MBBCh, MSc, MD

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Juul van den Reek, MD, PhD

Meet our Newest Councilors

Subscribe to the IPC Newsletter

Quick Links

Follow us